Detalhe da pesquisa
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
2.
Optimal systemic therapy in men with low-volume prostate cancer.
Curr Opin Urol
; 34(3): 183-197, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445371
3.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382533
4.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856213
5.
Approaches to Prevent and Manage Cardiovascular Disease in Patients Receiving Therapy for Prostate Cancer.
Curr Cardiol Rep
; 25(8): 889-899, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490155
6.
Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy.
Prostate
; 82(1): 41-48, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633087
7.
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805.
Prostate
; 82(12): 1176-1185, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538398
8.
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Prostate
; 82(12): 1202-1209, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652618
9.
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
J Natl Compr Canc Netw
; 20(12): 1288-1298, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509074
10.
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Prostate
; 81(7): 433-439, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792945
11.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215787
12.
Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?
Prostate
; 80(5): 399-406, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943289
13.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
14.
Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
Int J Gynecol Pathol
; 39(6): 587-594, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31567539
15.
Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review.
Radiographics
; 40(3): 709-726, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196428
16.
Challenges in clinical trials for high-risk but curable prostate cancer.
Cancer
; 130(9): 1575-1576, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340332
17.
Role of robot-assisted retroperitoneal lymph node dissection in malignant mesothelioma of the tunica vaginalis: case series and review of the literature.
Can J Urol
; 26(3): 9752-9757, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31180304
18.
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Cancer
; 124(3): 537-545, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044496
19.
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
PLoS Genet
; 10(2): e1004135, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550739
20.
Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer.
Oncology (Williston Park)
; 35(4): 166, 2021 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872479